Norgine Ventures
Overview
Norgine Ventures is an investment firm that provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Impress | Jul 2022 | Series B | Co-investor |
| Volta Medical | Jan 2023 | Series B | Co-investor |
| Agendia | Mar 2014 | Debt | Lead |
| Sirius Medical | Mar 2023 | Series B | Co-investor |
| Sirius Medtech | Mar 2023 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Norgine Ventures based?
Norgine Ventures is headquartered in Harefield, England, United Kingdom.
When was Norgine Ventures founded?
Norgine Ventures was founded in 2012.
How many portfolio companies does Norgine Ventures have?
Norgine Ventures has 9 portfolio companies in Caplight's dataset.
What are some companies in Norgine Ventures's portfolio?
Portfolio companies visible on Caplight include Impress, Volta Medical, Agendia, Sirius Medical, Sirius Medtech.
What was Norgine Ventures's most recent investment shown here?
Norgine Ventures's most recent investment in this portfolio sample was in Sirius Medical in 2023.
What sectors does Norgine Ventures focus on?
Norgine Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Consumer & Commerce, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Norgine Ventures focus on?
Norgine Ventures typically invests at the Mid stage.
What is Norgine Ventures's AUM?
Norgine Ventures's assets under management are estimated between $100.0M and $250.0M.